经皮肾动脉去神经消融得适应证与临床研究.pptVIP

* * * * * * * * * * * * * * * * * * * * * * * 长期安全性 81例患者进行了6个月的CTA、MRA或多普勒检查 1例患者肾动脉狭窄加重 not at a site of RF delivery possibly related to catheter manipulation successfully stented 肾功能无明显改变 (? eGFR) 12 Months: -2.9 mL/min/1.73m2 (n.s.) 随访中2例患者死亡，与本操作无关 Sadowski J, et al. Hypertension. 2011;57:911-917 治疗后血压的变化 92% of patients have BP ↓ BP change (mmHg) Sadowski J, et al. Hypertension. 2011;57:911-917 基线、12个月及24个月诊室血压分布 * Sadowski J, et al. Hypertension. 2011;57:911-917 38% 39% 3% 28% 56% 65% 22% 32% 13% 6% Baseline (n=150) 12 Months (n=64) 24 Months (n=18) ≥ 180 mmHg 160-179 mmHg 140-159 mm